CIDRAP newsletters options
Data yet to be peer-reviewed show the Omicron variant may be highly transmissible.
The plan comes as the nation records its 2nd and 3rd Omicron cases, in Minnesota and Colorado.
The US Department of Agriculture's (USDA's) Animal and Plant Health Inspection Service (APHIS) announced this week that it has begun an effort to study antimicrobial use and resistance on commercial swine farms in the Midwest.
The neutralizing monoclonal antibody lenzilumab significantly raised survival without the use of mechanical ventilation in hospitalized COVID-19 patients and had a good safety profile, according to a phase 3 clinical trial yesterday in The Lancet Respiratory Medicine.
Severe COVID-19 may bring more than twice the risk of dying within a year.
Delta-related COVID-19 activity showed signs of a plateau last week, the WHO says.
The case-patient traveled to South Africa and returned to the San Francisco area on Nov 22 and is isolating at home.
A third dose of the Pfizer/BioNTech mRNA COVID-19 vaccine appears to counteract waning vaccine protection in the short term, according to a preliminary case-control analysis of more than 500,000 coronavirus tests in Israel.
A study conducted in 15 hospitals found that discontinuing contact precautions for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) did not result in increased healthcare-associated infection (HAI) rates, researchers reported today in Infection Control & Hospital Epidemiology.
Merck's pill is on track to be the first approved treatment for COVID-19 infections.
Also, sequencing found hints that travelers with Omicron likely contracted the virus from different people in different locations.
Those with compromised immune systems get COVID-19 after vaccination 3 times more often—but still rarely—a new study shows.
Many COVID-19 survivors experience impaired circulation, abnormal breathing patterns, and chronic fatigue syndrome an average of 9 months after diagnosis, finds a small, single-center study yesterday in JACC: Heart Failure.
Global officials are assessing how the variant will affect the arc of the pandemic.
Heads of vaccine firms say they can quickly retool existing vaccines to address the variant if needed.
One study suggests the shots saved about 470,000 people 60 years and older in Europe.
During a meeting tomorrow at the Radiological Society of North America (RSNA), scientists will present data from the largest multi-institutional international study to date on brain complications of COVID-19 and share that 1 in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system like stroke, hemorrhage, and other potentially fatal complications.
A new report from the European Medicines Agency (EMA) shows sales of veterinary antimicrobials have fallen by more than 40% since 2011.
The US joins a growing list of nations that have banned flights from South Africa and related destinations.
Amid uncertainty about the meaning of the changes, intensive efforts are underway to gauge how the they might impact tests, treatments, and vaccine efficacy.
